论文部分内容阅读
目的探讨银杏酮酯分散片治疗冠心病对心电图ST段和血清超敏肌钙蛋白(hs-cTnT)水平的影响。方法将80例心电图ST段压低的冠心病患者随机分为两组,治疗组(银杏酮酯分散片)和对照组(复方丹参片)各40例,治疗前和治疗4周后对比心电图ST段和血清hs-cTnT水平的变化。结果心电图ST段压低得到改善治疗组35例,有效率87.5%;对照组22例,有效率55%;治疗组有效率显著高于对照组(P<0.01)。hs-cTnT下降治疗组23例,有效率57.5%;对照组22例,有效率55%,两组有效率的差异无统计学意义(P>0.05)。结论银杏酮酯分散片是可靠的冠心病治疗药物,能显著改善心肌缺血从而减少心肌梗死等风险。
Objective To investigate the effect of Ginkgo Biloba Tablets on the ECG ST segment and serum hs-cTnT level in patients with coronary heart disease (CHD). Methods Eighty patients with coronary heart disease with ST-segment depression were randomly divided into two groups. The treatment group (Ginkgo Ketone Ester Dispersible Tablets) and the control group (Danshen Tablets) 40 cases each. Before treatment and after 4 weeks of treatment, the electrocardiogram ST segment And serum hs-cTnT level changes. Results The electrocardiographic ST segment depression was improved in 35 cases in the treatment group, with an effective rate of 87.5%; in the control group, 22 cases were achieved with an effective rate of 55%. The effective rate of the treatment group was significantly higher than that of the control group (P <0.01). hs-cTnT decreased in 23 cases, the effective rate was 57.5%; control group, 22 cases, the effective rate was 55%. There was no significant difference between the two groups (P> 0.05). Conclusion Ginkgo biloba ester dispersible tablet is a reliable treatment of coronary heart disease, can significantly improve myocardial ischemia and thus reduce the risk of myocardial infarction.